FIELD: medicine, pharmacotherapy. SUBSTANCE: method involves prescription to patients 1-hydroxygermatran (germatranol, 1-hydroxy-1-germa-2,8,9-trioxa-5-azabicyclo-[3.3.3] -undecane) and its derivatives and/or derivatives of 1-germa-2,8-dioxa-5-azacyclooctane containing hydrogen or organic radicals and/or organoelemental radicals as substituent involving medicinal agent derivatives that were administrated orally, by injections or locally at dose 0.001-01 g/day. EFFECT: enhanced effectiveness of method. 5 cl, 8 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF POTENTIATION OF MEDICINAL AGENT CURATIVE EFFECT | 1997 |
|
RU2104032C1 |
| GERMANIUM BIOCHEMICAL COMPLEXES WITH HIGH THERAPEUTIC ACTIVITY AND BROAD SPECTRUM APPLYING | 1998 |
|
RU2233286C2 |
| TRIETHANOLAMINE TRICYCLIC ORGANOGERMANIC DERIVATIVES CITRATE SALTS AND METHOD FOR THEIR PREPARING | 2005 |
|
RU2293086C1 |
| SALTS OF 1-HYDROXYGERMATRANE WITH OXY-, KETO- AND DICARBONIC ACIDS | 2006 |
|
RU2333912C1 |
| COMPOUND STIMULATING DURING EXPERIMENT SYNTHESIS OF IMMUNOGLOBULINS | 1995 |
|
RU2108096C1 |
| USING 1-HYDROXYGERMATRANE MONOHYDRATE AS ACTOPROTECTING AGENT AND STIMULATING TISSUE RESPIRATION IN BODY AND METHOD FOR ITS PREPARING | 2005 |
|
RU2272624C1 |
| ANTIMICROBIAL RETENTION SUTURE | 2003 |
|
RU2237494C1 |
| ORAL PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY GASTROINTESTINAL DISEASES | 2010 |
|
RU2445965C2 |
| HYPOTHALAMO-HYPOPHYSEAL DRUG CAUSING IRREVERSIBLE INHIBITION AND/OR RESTING PHASE IN DOGS OR RESTING PHASE IN CATS | 1999 |
|
RU2139057C1 |
| AGENT FOR METABOLIC SYNDROME CORRECTION | 2011 |
|
RU2458935C1 |
